Eton Pharmaceuticals (ETON) Depreciation & Amortization (CF) (2018 - 2025)

Eton Pharmaceuticals (ETON) has 8 years of Depreciation & Amortization (CF) data on file, last reported at $1.0 million in Q4 2025.

• For the quarter ending Q4 2025, Depreciation & Amortization (CF) rose 186.48% year-over-year to $1.0 million; the trailing twelve-month figure through Dec 2025 stood at $4.0 million (up 252.88% YoY), and the FY2025 full-year result was $4.0 million, up 252.88% from the prior year.
• Depreciation & Amortization (CF) rose to $1.0 million in Q4 2025, from $1.0 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $1.2 million in Q2 2022 to a low of $85000.0 in Q2 2021.
• A 5-year average of $416350.0 and a median of $243000.0 in 2022 frame the typical range for Depreciation & Amortization (CF).
• Across the five-year window, Depreciation & Amortization (CF) soared 1277.65% in 2022 and plunged 85.31% in 2023, its largest moves.
• Tracing ETON's Depreciation & Amortization (CF) over 5 years: stood at $137000.0 in 2021, then surged by 83.94% to $252000.0 in 2022, then gained by 28.97% to $325000.0 in 2023, then gained by 9.23% to $355000.0 in 2024, then surged by 186.48% to $1.0 million in 2025.
• Business Quant data shows ETON's Depreciation & Amortization (CF) at $1.0 million in Q4 2025, $1.0 million in Q3 2025, and $1.0 million in Q2 2025.